Therapeutics

Bio Roundup: Cerevel's Shell, Thrive's Rise, Drug Price Drama & More

14 days ago   |   By Xconomy

The biotech IPO market is buzzing but Cerevel Therapeutics is showing that there's more than one path to the public markets. This week the neuroscience drug developer reached a deal to merge with publicly traded Arya Sciences Acquisition Corp II. If you've never heard of Arya , it's a shell company that Perceptive Advisors formed specifically to serve as a vehicle to take a private company public. Cerevel is young, but it's pretty far along. Bain Capital and Pfizer launched it in 2018 with neuroscience compounds from the pharma giant's labs. Now Arya and a...
Read more ...

 


Search by Tags

   Therapeutics      BioTech      Biotech      Science      Drug      Drugs      Neurosciences      Neuroscience      Pharma      Boston blog main      Boston top stories      Boulder      Denver blog main      Denver top stories      Detroit blog main      Detroit top stories      Europe blog main      Europe top stories      Indiana blog main      Indiana top stories      National      National blog main      National top stories      New York blog main      New York top stories      Philadelphia Blog Main      Philadelphia Top stories      Raleigh-Durham blog main      Raleigh-Durham top stories      San Diego blog main      San Diego top stories      San Francisco blog main      San Francisco top stories      Seattle blog main      Seattle top stories      Texas blog main      Texas top stories      Wisconsin blog main      Wisconsin top stories      8VC      AbbVie      Alentis Therapeutics      AlloVir      Alzheimer's disease      Andrew Joe      Annexon Biosciences      Antoine Awad      Anxiety      Arcutis Biotherapeutics      AristaMD      Arya Sciences Acquisition Corp II      AstraZeneca      Atogepant      Autism      Avidity Biosciences      Bain Capital      BioNtech      Biotech IPOs      BlueBird Bio      Brexucabtagene autoleucel      Bright Peak Therapeutics      Bristol-myers Squibb      Cancer      Cell Therapy      Cerevel Therapeutics      CureVac      Dagmar Rosa-Bjorkeson      Daiichi Sankyo      Deals      Diagnostics      DNA Script      Donald Trump      Drug prices      Editas Medicine      Endocrine Diseases      Engrail Therapeutics      Entera      Epigenomics      F-star Therapeutics      Frazier Healthcare Partners      Gad Berdugo      Genentech      Gilead Sciences      GlaxoSmithKline      Huntington's Disease      Idecabtagene vicleucel      Inflammatory Diseases      Inhibrx      Jae Kim      Kellie Malloy Foerter      Kimberly Vanover      La Jolla Pharmaceutical      Larry Edwards      Life Sciences      Mantle cell lymphoma      Mantra Bio      MBX Biosciences      Merus      Mesoblast      Messenger RNA      Michael Overdorf      Migraine      ModeRNA      Multiple Myeloma      Novartis      Nura Bio      Omega Therapeutics      OncoSec      Parkinson's Disease      Patrick Burnett      Perceptive Advisors      Pfizer      Pneumonia      Praxis Precision Medicines      Rheumatoid Arthritis      Roche      Sangamo Therapeutics      Sanofi      Schizophrenia      Sema4      SmartPharm      Sofinnova Partners      Solid Bio      Sorrento Therapeutics      Spinocerella      Spring Bank Pharmaceuticals      Synlogic      Telehealth      The Column Group      Thrive Earlier Detection      Tocilizumab      UCB      Versant Ventures      Vico Therapeutics      Viking Global Investors  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

How COVID-19 Arose and Amplified Along the Meat Supply Chain

How COVID-19 Arose and Amplified Along the Meat Supply Chain

Early in this unforgettable year, a wet market in Wuhan, China, emerged as a possible step along the way, if not the place of origin, of the outbreak that would seed the... Read more ...

Global Methane Emissions Soaring, But How Much Was Due to Wetlands?

Global Methane Emissions Soaring, But How Much Was Due to Wetlands?

Infographic published with permission from the authors of “Increasing anthropogenic methane emissions arise equally from agricultural and fossil fuel sources.” (Credit: Jackson... Read more ...

Computer System Assurance: A Paradigm Shift Away from Compliance to Quality

Computer System Assurance: A Paradigm Shift Away from Compliance to Quality

Our Professional Services Written by: Gary E. Ritchie, MS, Senior Validation Engineer Consultant, PSC Biotech Corporation The FDA will release the draft guidance on Computer... Read more ...

With FDA Nod, NS Pharma Duchenne Drug Becomes Sarepta Competitor

With FDA Nod, NS Pharma Duchenne Drug Becomes Sarepta Competitor

Duchenne muscular dystrophy patients whose disease is characterized by a particular genetic mutation now have a new treatment option following the FDA's Wednesday approval of a... Read more ...

Perceptive Advisors' LianBio Inks Deals With BridgeBio, MyoKardia

Perceptive Advisors' LianBio Inks Deals With BridgeBio, MyoKardia

Two California biotechs have teamed up with LianBio, a new company launched earlier this week by hedge fund Perceptive Advisors, as part of deals that expand their reach into... Read more ...

F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections

F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections

Fungal infections might not immediately come to mind as rare diseases, but growing resistance to older drugs means that patients who develop these infections have limited... Read more ...

Calliditas gets controlling stake, option to buy out Genkyotex and its...

Calliditas gets controlling stake, option to buy out Genkyotex and its failed PBC drug badams Fri, 08/14/2020 - 05:07 Read more ...

17β-Estradiol affects the innate immune response in common carp

Abstract Inflammation is the evolutionary conserved immune response to harmful stimuli such as pathogens or damaged cells. This multistep process acts by removing injurious... Read more ...

Chutes & Ladders-WuXi taps veteran operations head Dong to lead new vaccines...

Chutes & Ladders-WuXi taps veteran operations head Dong to lead new vaccines unit kblankenship Fri, 08/14/2020 - 08:23 Read more ...

Team discovers a new role for a well-known molecule as a plant hormone

Researchers at the University of Maryland have discovered an entirely new role for a well-known plant molecule called ACC, providing the first clear example of ACC acting on... Read more ...